Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Revenue Projected To Hit $2.27 Billion By 2030 With 23% CAGR
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Expected To Scale Between 2026 And 2030?
The market for artificial intelligence (AI) tele-oncology radiation dose schedulers has experienced exponential expansion in recent years. It is projected to grow from $0.81 billion in 2025 to $0.99 billion in 2026, at a compound annual growth rate (CAGR) of 23.3%. This historical growth can be attributed to a variety of factors, including the increasing need for remote cancer treatment planning, the rising adoption of tele-oncology platforms, a growing demand for precise radiation dose calculation, the expanding use of AI in oncology decision support, a rising global cancer incidence, the accelerating digital transformation within hospitals, the increasing deployment of cloud-based medical systems, a growing need for workflow automation in radiotherapy, a heightened focus on reducing treatment errors, and the increasing adoption of smart oncology scheduling tools.
The artificial intelligence (AI) tele-oncology radiation dose scheduler market size is projected for significant expansion in the coming years, expected to reach $2.28 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 23.0%. This growth during the forecast period is attributed to several factors, including the expansion of tele-oncology networks, the increasing adoption of AI-enabled treatment planning platforms, a rising demand for automated dose calculation systems, the uptake of cloud-based oncology scheduling modules, the deployment of predictive oncology algorithms, the development of remote radiotherapy review tools, the growing need for precision-based cancer care, the integration of AI tools into oncology departments, partnerships between AI vendors and cancer centers, and the growing acceptance of tele-radiation workflows. Furthermore, major trends anticipated in this period encompass advancements in AI-driven radiotherapy dose prediction, enhancements in cloud-based oncology scheduling platforms, progress in real-time dose optimization engines, innovations in automated treatment planning systems, breakthroughs in predictive oncology algorithms, novelties in virtual radiation oncology workflows, the integration of tele-oncology with hospital information systems, the merging of AI dose schedulers with imaging platforms, the incorporation of remote dose-review tools for oncologists, and the establishment of multi-center tele-radiation networks.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=30520&type=smp
What Major Factors Are Driving The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Forward?
The increasing incidence of cancer is anticipated to fuel the expansion of the artificial intelligence (AI) tele-oncology radiation dose scheduler market moving forward. Cancer is defined as a condition involving the uncontrolled multiplication and spread of atypical cells, capable of damaging adjacent tissues and organs if not effectively addressed. This escalating occurrence of cancer is attributed to lifestyle factors such as inadequate nutrition, tobacco use, alcohol consumption, and exposure to environmental pollutants, which heighten the risk of developing various forms of cancer. Artificial intelligence (AI) tele-oncology radiation dose schedulers assist in managing cancer by optimizing and personalizing radiation treatment plans through remote, data-informed analysis. These systems improve patient outcomes by guaranteeing precise dosages, minimizing treatment delays, and enabling uniform care across different locations. For instance, in October 2025, according to NHS Digital, a UK government organisation, 354,820 new cancer diagnoses were recorded in England in 2023, averaging 972 diagnoses per day, which represented an increase of 8,605 cases compared to 2022. Prostate cancer was the most commonly diagnosed cancer, with 58,137 new cases, reflecting a 6% increase in registrations compared to the previous year. Consequently, the rising prevalence of cancer is driving the growth of the artificial intelligence (AI) tele-oncology radiation dose scheduler market.
How Is The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Categorized Across Its Segment Groups?
The artificial intelligence (AI) tele-oncology radiation dose scheduler market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning Algorithms, Natural Language Processing, Computer Vision, Predictive Analytics
3) By Deployment Mode: On-Premise (Local Installation), Cloud-Based (SaaS), Hybrid Deployment
4) By Application: Auto-Contouring And Segmentation (OAR Or Target), Treatment Plan Generation And Optimization, Dose Prediction And Quality Assurance (QA), Workflow And Resource Scheduling Optimization, Adaptive Radiotherapy Planning
5) By End-User: Hospitals, Cancer Treatment Centers, Research Institutes, Other End-Users
Subsegments:
1) By Software: Analytics And Reporting Software, Recommendation Engine Software, Natural Language Processing Software, Machine Learning Model Management Tools, Computer Vision Software, Integration And API Management Software, Mobile And Web Application Software
2) By Hardware: AI-Optimized Servers, Edge Computing Devices, Sensors And IoT Devices, Smart Cameras, GPUs And AI Accelerators, Storage Systems, Networking And Connectivity Hardware
3) By Services: Consulting Services, Implementation And Integration Services, Training And Support Services, Managed AI Services, Maintenance And Upgradation Services, Custom AI Development Services, Data Management And Annotation Services
Which Trends Are Impacting The Progress Of The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market?
Major companies engaged in the AI tele-oncology and radiation therapy market are concentrating on developing advanced solutions, such as AI-powered dose prediction, to forecast personalized radiation dose distributions and enhance the efficiency of treatment planning. These AI-powered dose prediction platforms are software solutions utilized to analyze imaging and anatomical data, generate clinically achievable three-dimensional dose distributions, and support timely adjustments for therapy optimization. For instance, in March 2025, MVision AI, a Finland-based health-tech company, introduced Dose+. This AI-powered dose prediction platform incorporates specialized models for prostate and pelvic lymph node cases, customizes dose distributions to each patient’s anatomy, and supports integration with standard treatment planning systems via DICOM to facilitate efficient planning workflows. This launch signifies a substantial technological advancement by integrating AI-driven dose prediction into routine clinical practice, bridging traditional planning with automated, patient-specific optimization, and providing clinicians with a scalable, efficient solution for precise, personalized radiation therapy.
Which Firms Are Influencing Competition In The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market?
Major companies operating in the artificial intelligence (AI) tele-oncology radiation dose scheduler market are IBM Corporation, Siemens Healthineers AG, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Varian Medical Systems Inc., Elekta AB, Shanghai United Imaging Healthcare Co. Ltd., Accuray Incorporated, Brainlab AG, RaySearch Laboratories AB, MIM Software Inc., Sun Nuclear Corp., DeepHealth, Radformation Inc., MVision AI Ltd., Mirada Medical Ltd., ViewRay Inc., Oncora Medical, Enlitic, Optellum Ltd.
Get The Full Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Report:
Which Region Represents The Largest Share Of The Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market?
North America was the largest region in the AI tele-oncology radiation dose scheduler market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) tele-oncology radiation dose scheduler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=30520&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) Tele-Oncology Radiation Dose Scheduler Market 2026, By The Business Research Company
Artificial Intelligence In Oncology Market Report 2026
Radiation Dose Management Market Report 2026
https://www.thebusinessresearchcompany.com/report/radiation-dose-management-global-market-report
artificial intelligence ai radiology tool global market report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
